Startup · Healthcare · Hardware
Continuous lactate biosensors for real-time fetal monitoring
Perth, WA
Every investor coverage indicates participated in a round VitalTrace raised.
| Investor | Rounds | Invested |
|---|---|---|
| Fund WA | Grant | - |
| WA Future Health Research and Innovation Fund | Grant | - |
| Medtech Actuator | Accelerator | - |
| State Government | Accelerator | - |
Investors whose own portfolio pages list VitalTrace, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Artesian VC | its portfolio page ↗ |
| Artesian VC | its portfolio page ↗ |
Companies VitalTrace acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Arjun Kaushik | Founder and CEO | Startup News (WA), VitalTrace team page |
| Dr Lee Hubble | Chief Scientific Officer | VitalTrace team page |
Stories naming VitalTrace. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
FundWA has backed Perth medtech VitalTrace as the second deal from its debut fund. The biosensor startup's co-founders took out a 2021 WA Innovator of the Year award.
MedTech Actuator alumni are behind Synthesis Capital, a new venture fund courting investors for up to $100m to back young health technology companies across Australia and the Asia-Pacific.